The p21-activated Kinase PAK3 Forms Heterodimers with PAK1 in Brain Implementing Trans-regulation of PAK3 Activity

被引:21
|
作者
Combeau, Gaelle
Kreis, Patricia
Domenichini, Florence
Amar, Muriel
Fossier, Philippe
Rousseau, Veronique
Barnier, Jean-Vianney [1 ]
机构
[1] Univ Paris 11, Ctr Neurosci Paris Sud, UMR 8195, F-91405 Orsay, France
关键词
LONG-TERM POTENTIATION; MENTAL-RETARDATION; MISSENSE MUTATION; NERVE-TERMINALS; SPLICE VARIANTS; PROTEIN-KINASE; ACTIVATION; PATHWAY; MECHANISM; CDC42;
D O I
10.1074/jbc.M112.355073
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p21-activated kinase 1 (PAK1) and PAK3 belong to group I of the PAK family and control cell movement and division. They also regulate dendritic spine formation and maturation in the brain, and play a role in synaptic transmission and synaptic plasticity. PAK3, in particular, is known for its implication in X-linked intellectual disability. The pak3 gene is expressed in neurons as a GTPase-regulated PAK3a protein and also as three splice variants which display constitutive kinase activity. PAK1 regulation is based on its homodimerization, forming an inactive complex. Here, we analyze the PAK3 capacity to dimerize and show that although PAK3a is able to homodimerize, it is more likely to form heterodimeric complexes with PAK1. We further show that two intellectual disability mutations impair dimerization with PAK1. The b and c inserts present in the regulatory domain of PAK3 splice variants decrease the dimerization but retain the capacity to form heterodimers with PAK1. PAK1 and PAK3 are co-expressed in neurons, are colocalized within dendritic spines, co-purify with post-synaptic densities, and co-immunoprecipitate in brain lysates. Using kinase assays, we demonstrate that PAK1 inhibits the activity of PAK3a but not of the splice variant PAK3b in a trans-regulatory manner. Altogether, these results show that PAK3 and PAK1 signaling may be coordinated by heterodimerization.
引用
收藏
页码:30084 / 30096
页数:13
相关论文
共 50 条
  • [1] Interaction of paxillin with p21-activated kinase (PAK) -: Association of paxillin α with the kinase-inactive and the Cdc42-activated forms of PAK3
    Hashimoto, S
    Tsubouchi, A
    Mazaki, Y
    Sabe, H
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (08) : 6037 - 6045
  • [2] Distinct, but compensatory roles of PAK1 and PAK3 in spine morphogenesis
    Boda, Bernadett
    Jourdain, Lorena
    Muller, Dominique
    HIPPOCAMPUS, 2008, 18 (09) : 857 - 861
  • [3] Sequence analysis of P21-activated kinase 3 (PAK3) in chronic schizophrenia with cognitive impairment
    Morrow, Eric M.
    Kane, Anna
    Goff, Donald C.
    Walsh, Christopher A.
    SCHIZOPHRENIA RESEARCH, 2008, 106 (2-3) : 265 - 267
  • [4] p21-activated kinase 3 (PAK3) is a cJun regulated gene that associates with AP-1 induced oncogenesis
    Holderness, N.
    Donninger, H.
    Birrer, M.
    Leaner, V.
    FEBS JOURNAL, 2011, 278 : 217 - 217
  • [5] The kinase-inhibitory domain of p21-activated kinase 1 (PAK1) inhibits cell cycle progression independent of PAK1 kinase activity
    M Thullberg
    A Gad
    A Beeser
    J Chernoff
    S Strömblad
    Oncogene, 2007, 26 : 1820 - 1828
  • [6] The kinase-inhibitory domain of p21-activated kinase 1 (PAK1) inhibits cell cycle progression independent of PAK1 kinase activity
    Thullberg, M.
    Gad, A.
    Beeser, A.
    Chernoff, J.
    Stromblad, S.
    ONCOGENE, 2007, 26 (12) : 1820 - 1828
  • [7] p21-Activated Kinase 3 (PAK3) Is an AP-1 Regulated Gene Contributing to Actin Organisation and Migration of Transformed Fibroblasts
    Parker, Nina Holderness
    Donninger, Howard
    Birrer, Michael J.
    Leaner, Virna D.
    PLOS ONE, 2013, 8 (06):
  • [8] Integration of hepatitis B virus DNA into p21-activated kinase 3 (PAK3) gene in HepG2.2.15 cells
    Ruan, Peng
    Dai, Xiufang
    Sun, Jun
    He, Chunping
    Huang, Chao
    Zhou, Rui
    Chemin, Isabelle
    VIRUS GENES, 2020, 56 (02) : 168 - 173
  • [9] p21-activated kinase 1 (PAK1) as a therapeutic target for cardiotoxicity
    Guo, Ping
    Liu, Yufeng
    Feng, Jingrong
    Tang, Shihang
    Wei, Fanyan
    Feng, Jian
    ARCHIVES OF TOXICOLOGY, 2022, 96 (12) : 3143 - 3162
  • [10] p21-activated kinase 1 (PAK1) as a therapeutic target for cardiotoxicity
    Ping Guo
    Yufeng Liu
    Jingrong Feng
    Shihang Tang
    Fanyan Wei
    Jian Feng
    Archives of Toxicology, 2022, 96 : 3143 - 3162